Back to search
FDAFDA · Food and drugs·Recall number D-0733-2026

Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99

Published August 12, 2026 · Recall initiated: July 23, 2026

Summary

FDA records drug Class II recall D-0733-2026, published August 12, 2026 and initiated July 23, 2026. Recalling firm: Aurobindo Pharma USA Inc; Status: Ongoing; Reported quantity: 6,408 bottles distributed to market; Lot: Batch # DMC125018A, Exp Date: 07/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

shortfill; reports of empty capsules.

What to do

Voluntary: Firm initiated · Letter

Get an email if DICYCLOMINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DICYCLOMINE HYDROCHLORIDE
Manufacturer
Aurobindo Pharma USA Inc
Distributor
US Nationwide.
UPC
0359651719015
Lot
Batch # DMC125018A, Exp Date: 07/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99 recalled?

Yes. FDA published recall D-0733-2026 on August 12, 2026. Reported hazard: shortfill; reports of empty capsules.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DICYCLOMINE HYDROCHLORIDE. UPC: 0359651719015.